Findings

What do systematic reviews say?

6 questions · 8 findings · 1 reviews · Vascular

No studies found 1 · 12.5%GRADE not reported 0 · 0%Very low 0 · 0%Low 7 · 87.5%Moderate 0 · 0%High 0 · 0%

All‐cause mortality, 30 days1 · patients of any age with AAA less than 30 mm in diameter

Metoprolol showed no clear difference in all‐cause mortality, 30 days1 compared with placebo (low certainty).

1 finding from 1 review

All cardiovascular death · patients of any age with AAA less than 30 mm in diameter

Metoprolol showed no clear difference in cardiovascular death, 30 days3 compared with placebo (low certainty).

2 findings from 1 review

AAA‐related death, 30 days4 · patients of any age with AAA less than 30 mm in diameter

Metoprolol showed no clear difference in AAA‐related death, 30 days4 compared with placebo (low certainty).

2 findings from 1 review

Nonfatal cardiovascular event, 30 days5 · patients of any age with AAA less than 30 mm in diameter

Metoprolol showed no clear difference in nonfatal cardiovascular event, 30 days5 compared with placebo (low certainty).

1 finding from 1 review

All‐cause mortality, 6 months1 · patients of any age with AAA less than 30 mm in diameter

Metoprolol showed no clear difference in all‐cause mortality, 6 months1 compared with placebo (low certainty).

1 finding from 1 review

Non‐fatal cardiovascular events · patients of any age with AAA less than 30 mm in diameter

Metoprolol showed no clear difference in nonfatal cardiovascular event, 6 months5 compared with placebo (low certainty).

1 finding from 1 review